Analyst Ratings for Quince Therapeutics Inc. (QNCX)
QNCX Rating Summary
QNCX Price Target Summary
- Highest: $82.00 (Oppenheimer)
- Lowest: $4.00 (Leerink)
- Average: $63.29
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$63.29 (+99.5%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 76%
Avg. $ Target:
$63.29 (+99.5%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/9/2026 | Raymond James | Tiago Fauth | New Coverage | Outperform (N/A) |
72.00 (N/A) |
29.36 (31.73) |
8.07% | Details |
| 9/24/2026 | Rodman & Renshaw | Seema Sheoran | New Coverage | Buy (N/A) |
70.00 (N/A) |
30.15 (31.73) |
5.24% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
